Final results of UK NCRI phase II trial of pembrolizumab and radiotherapy in cutaneous T cell lymphoma

The outlook for patients with advanced cutaneous T-cell lymphomas (CTCL); mycosis fungoides (MF) and Sézary syndrome (SS) remains poor and most systemic treatments provide short-lived remissions. Immunotherapy has provided a major cancer breakthrough, and the PORT trial was designed to investigate...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Timothy Illidge, William Wilson, James Paterson, Andrew Bates, Eleanor Cheadle, Graham Collins, Richard Cowan, Nadjet El-Mehidi, Eve Gallop-Evans, Eleanor James, Toyin Adedayo, Wendy Osborne, Noelle O’Rourke, Joya Pawade, Julia Scarisbrick, Jeff Ward, Sean Whittaker, Stephen Morris
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Ferrata Storti Foundation 2026-07-01
סדרה:	Haematologica
גישה מקוונת:	https://haematologica.org/article/view/14301
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!